Ycanth (cantharidin) topical solution 0.71% for the treatment of molluscum contagiosum launched in Japan – Torii Pharma/Shionogi

Shionogi & Co., Ltd. announces that its group company, Torii Pharmaceutical Co., Ltd., has issued a press release about the launch in Japan of Ycanth (cantharidin)  topical solution 0.71% for the treatment of molluscum contagiosum.

This product received manufacturing and marketing approval in Japan for the indication of molluscum contagiosum, a common pediatric skin infection, on September 19, 2025, and has been listed on the Japanese National Health Insurance (NHI) drug price list on November 12, 2025.